Key result
Heart rate and blood pressure differ among healthy controls, athletes with LVH, and hypertensive patients.
Why the study?
Hypertensive LVH causes significant morbidity and mortality, but shares a concentric hypertrophy pattern with benign physiologic hypertrophy in athletes, prompting the need to distinguish between them using speckle tracking echocardiography.
Can speckle tracking echocardiography differentiate mild left ventricular hypertrophy in athletes from hypertensive left ventricular hypertrophy?
RCT (n=105)
randomly assigned
Can speckle tracking echocardiography differentiate mild left ventricular hypertrophy in athletes from hypertensive left ventricular hypertrophy?
The study highlights significant baseline hemodynamic differences between athletes, hypertensive patients, and healthy controls, though the abstract omits the primary speckle tracking results.
Baseline hemodynamic differences warrant caution in LVH assessment; leaves open whether speckle tracking differentiates athletic from hypertensive hypertrophy.
Hypertensive cardiac hypertrophy is a leading cause of morbidity and death, which motivates our study's focus on these issues. Conditions include heart attacks, irregular heartbeats, diastolic dysfunction, heart failure, and sudden cardiac death fall under this category. A concentric cardiac hypertrophy pattern, like that seen in hypertensive hypertrophy, is also seen in athletes who participate in intense strength training. On the other hand, unlike hypertension hypertrophy, which may have dire consequences, athletic hypertrophy is generally seen as a harmless physiologic response. The research aimed to use speckle tracking echocardiography to identify mild LVH in athletes and distinguish it from hypertensive LVH in patients. A total of 105 participants were included in this prospective case control study and were randomly assigned to one of three groups: 45 healthy, inactive people served as the "healthy group." Patients with hypertension-related LVH numbered 30, whereas athletes with concentric LVH numbered 30 in the athletes group. The results showed that there were no statistically significant differences (p>0.05) in age, height, or body mass index between the groups that were analysed. The mean body mass index was significantly different between the three groups (p= 0.005). Heart rate, systolic blood pressure, and diastolic blood pressure all differed significantly (p0.001) across the three groups. The heart rates of the healthy and athletic groups were found to be significantly lower than those of the hypertension group.
No takes yet. Share an insight, caveat, or question.
Alrabat et al. (2022) conducted an RCT in Hypertensive cardiac hypertrophy and athlete's moderate left ventricular hypertrophy (n=105). Speckle tracking echocardiography vs. Healthy inactive controls was evaluated on Differentiation of mild LVH in athletes from hypertensive LVH in patients. In a study of 105 participants, heart rate, systolic blood pressure, and diastolic blood pressure differed significantly (p=0.001) between healthy controls, athletes with LVH, and hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: